Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.12 USD | +6.06% | -2.68% | +39.00% |
Feb. 09 | Oppenheimer Adjusts Enanta Pharmaceuticals Price Target to $17 From $21, Maintains Perform Rating | MT |
Feb. 07 | Transcript : Enanta Pharmaceuticals, Inc., Q1 2024 Earnings Call, Feb 07, 2024 |